Health & Fitness Lupin's COVID-19 drug Molnupiravir launched in India The Medicine Controller General of India (DCGI) has issued the drug emergency use authorization for the treatment of adult COVID-19 patients By Connect Gujarat Desk 07 Jan 2022 Share Twitter Share Whatsapp LinkedIn
/connect-gujarat-english/media/post_banners/7cc27b278f9fd006e0081ebc06e2fa6f174e54e8c9ee868bcf652fbc10d59140.webp)
/connect-gujarat-english/media/post_banners/6f8d86fc15ad631cb3d1107042431d13e2987d40f1aee222c02be15dedcacc52.webp)